Literature DB >> 7673172

Distinct characteristics of the basal activities of adenylyl cyclases 2 and 6.

J P Pieroni1, A Harry, J Chen, O Jacobowitz, R P Magnusson, R Iyengar.   

Abstract

Regulation of basal activities of adenylyl cyclase (AC) 2 and 6, expressed in Sf9 cells by infection with recombinant baculovirus, was studied. An antipeptide antibody that recognizes AC2 and AC6 with equal sensitivity was used to establish that equivalent levels were expressed. Basal activities of AC2 and AC6 were compared at varying concentrations of Mg2+ or Mn2+ ions; AC2 had 15- and 10-fold greater activity than AC6, respectively. At 20 mM Mg2+, the Km values for ATP were 88 and 39 microM for AC2 and AC6, respectively, whereas their Vmax values were 281 and 11 pmol/mg protein.min. With 100 microM forskolin and either Mg2+ or Mn2+, the difference in activities between AC2 and AC6 was reduced to approximately 2-fold. Forskolin stimulated AC6 greater than 40-fold at 0.5-2 mM Mg2+, whereas AC2 was stimulated 4-6-fold. At 20 mM Mg2+, AC2 was stimulated 2-fold by forskolin, whereas AC6 was stimulated 18-fold. With Mg2+ alone, activities of AC2 and AC6 were not saturable up to 20 mM and yielded curvilinear Hofstee transformations. With forskolin, activities of both AC2 and AC6 were saturable by 10 mM Mg2+ and yielded linear Hofstee transformations. These data indicate that there are substantial differences in the basal enzymatic activities of adenylyl cyclase isoforms, due to differential regulation by Mg2+ ions rather than intrinsic catalytic capabilities. Thus the presence and relative abundance of adenylyl cyclase subtypes could greatly affect the resting cellular cAMP levels with consequent effects on important biological functions, such as differentiation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673172     DOI: 10.1074/jbc.270.36.21368

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

2.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 3.  Toward predictive models of mammalian cells.

Authors:  Avi Ma'ayan; Robert D Blitzer; Ravi Iyengar
Journal:  Annu Rev Biophys Biomol Struct       Date:  2005

4.  Agonist regulation of adenylate cyclase activity in neuroblastoma x glioma hybrid NG108-15 cells transfected to co-express adenylate cyclase type II and the beta 2-adrenoceptor. Evidence that adenylate cyclase is the limiting component for receptor-mediated stimulation of adenylate cyclase activity.

Authors:  D J MacEwan; G D Kim; G Milligan
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

5.  Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.

Authors:  Cibele Pinto; Gerald H Lushington; Mark Richter; Andreas Gille; Jens Geduhn; Burkhard König; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

6.  Type VI adenylyl cyclase regulates neurite extension by binding to Snapin and Snap25.

Authors:  Chia-Shan Wu; Jiun-Tsai Lin; Chen-Li Chien; Wei-Cheng Chang; Hsing-Lin Lai; Ching-Pang Chang; Yijuang Chern
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

Review 7.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

8.  Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.

Authors:  Jason M Conley; Cameron S Brand; Amy S Bogard; Evan P S Pratt; Ruqiang Xu; Gregory H Hockerman; Rennolds S Ostrom; Carmen W Dessauer; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2013-09-05       Impact factor: 4.030

9.  Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.

Authors:  Amy S Bogard; Piyatilake Adris; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2012-05-22       Impact factor: 4.030

10.  Insights into the Regulatory Properties of Human Adenylyl Cyclase Type 9.

Authors:  Tanya A Baldwin; Yong Li; Cameron S Brand; Val J Watts; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.